Medtronic to expand Chinese presence with Weigao partnership

12/18/2007 | MarketWatch · Wall Street Journal (free content), The

Medtronic has agreed to purchase a 15% stake in Shandong Weigao Group Medical Polymer Co. for $221 million to expand its presence in China. The deal, which would allow both firms to offer devices for the treatment of orthopedic and spinal injuries, is expected to enhance Weigao's product quality and increase its product lines, the company's chairman said.

View Full Article in:

MarketWatch · Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ